Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
88.01
-0.08 (-0.09%)
After Hours: 87.98 -0.03 (-0.03%)
May 20, 7:57PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 87.81 - 88.20
52 week 61.71 - 88.20
Open 88.10
Vol / Avg. 7.24M/9.78M
Mkt cap 239.77B
P/E 23.95
Div/yield 0.66/3.00
EPS 3.67
Shares 2.72B
Beta 0.55
Inst. own 71%
Jul 15, 2013
Q2 2013 Johnson & Johnson Earnings Release Add to calendar
May 23, 2013
Johnson & Johnson to Host Pharmaceuticals Business Review for Investment Community - 3:00PM EDT - Add to calendar
Apr 25, 2013
Johnson & Johnson Annual Shareholder Meeting
Apr 16, 2013
Q1 2013 Johnson & Johnson Earnings Conference Call
Apr 16, 2013
Q1 2013 Johnson & Johnson Earnings Release
Feb 25, 2013
Johnson & Johnson at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 19.98% 15.64%
Operating margin 24.34% 20.49%
EBITD margin - 30.93%
Return on average assets - 8.95%
Return on average equity - 17.81%
Employees 127,600 -
Carbon Disclosure Rating - 93/100

Address

One Johnson & Johnson Plaza
NEW BRUNSWICK, NJ 08933
United States - Map
+1-732-5240400 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia
Discussion Group - Google Finance

Description

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. The Company�s primary focus has been on products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Company's subsidiaries operate 146 manufacturing facilities occupying approximately 21.6 million square feet of floor space. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition Of Flexible Stenting Solutions, Inc.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 54
Bio & Compensation  - Reuters
Paulus Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 51
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
Mary Sue Coleman Ph.D Independent Director
Age: 69
Bio & Compensation  - Reuters
James G. Cullen Presiding Independent Director
Age: 70
Bio & Compensation  - Reuters
Ian E. L. Davis Independent Director
Age: 62
Bio & Compensation  - Reuters